Acadia Pharmaceuticals Inc.’s Post

What DEI efforts in life science have been successful? This #PrideMonth, we’re amplifying LGBTQIA+ voices in the industry. Robert Bell, Associate Director, Commercial Field Training at Acadia Pharmaceuticals Inc., shares: "Clinical trial diversity has become of utmost importance and life science companies are taking deliberate steps to widen their applicant base. One tactic I’ve seen is making the process available in a multitude of languages. At Acadia, we believe that positive outcomes for all is important, and having a diverse clinical trial set is critical in realizing those positive outcomes. Though we’re still in the formative stages of our journey, Acadia has taken solid steps towards inclusivity. It has been named as a priority, and commitment and is front and center (website, onboarding, even our values). We launched work streams focusing on DEI amongst our employees, patients and community. What I am most excited about is our aim to bolster a feeling of belonging through learning and employee resource groups (Rainbow Alliance, Women @ Work, Mosaic and B.O.L.D.). Because what good is inclusive recruiting if folks don’t feel comfortable once they are here?"

How to make community events more diverse, accessible & inclusive 👇 Proud to be part of an organisation that is transparent about diversity, equality and inclusivity at its own events. Here's the deliberate action we are taking to be better: https://lnkd.in/gpBu57Eu

Landmark Report Published on the Status of Inclusion, Diversity, Equity and Accessibility (IDEA) in Canada’s Life Sciences Sector "Inclusion, diversity, equity and accessibility are not just buzzwords," says Dr. Jason Field, President and CEO of Life Sciences Ontario. "They are indispensable pillars for the life sciences sector. By fostering an inclusive and diverse workforce, organizations unlock an unparalleled capacity for innovation, creativity, and excellence. We are hoping that this report serves as a resounding call to action for all organizations, big or small, to embrace the principles of IDEA and harness the untapped potential within their ranks."

October is Diversity Awareness Month! Earlier this year, our CEO, Mark I. Weinberger, PhD, MPH, shared insightful thoughts on the importance of community fit and diversity in clinical research acquisitions. "Diversity in clinical trials is not just a nice-to-have; it's a must-have. It's about ensuring that treatments work for everyone, regardless of their background," Dr. Weinberger emphasizes. Read the full blog here: https://lnkd.in/gCY5f2ib Let's continue the conversation on diversity and inclusion in research during #GlobalDiversityAwarenessMonth. Together, we can make healthcare more equitable and accessible for all. #DiversityMatters #Inclusion #HealthEquity #ClinicalResearch

Check out my colleague, Bettina Ploder, and learn about her her journey to her current role, Director of Biostatistics, where she's responsible for all statistical related activities of clinical studies across Takeda. Read more about the work Bettina does and how she sees Takeda supporting women in science. #WomenInSTEM #WomenInScience #WomenInBiopharma #TeamTakeda

If you missed our report release on the "Status of Inclusion, Diversity, Equity and Accessibility in the Life Sciences Sector" on July 20th or would like to relive the highlights of the event held at MaRS Discovery District, we have you covered. This report provides a comprehensive analysis of the current state of IDEA within Canada’s life sciences sector, and it sheds light on the progress, challenges and opportunities that are shaping IDEA within our industry. It provides important recommendations for shaping policies, strategies and initiatives that will drive positive change. Link to the report: https://lnkd.in/gX_TiAr8 https://lnkd.in/gfduGmNA cc Shift Health Pfizer adMare BioInnovations American Chamber of Commerce in Canada (AmCham Canada) #inclusivity, #diversity, #equity, #accessibility

According to the State of Diversity, Equity, Inclusion & Belonging in Life Sciences report, the importance of DEI has declined across all genders, races, and age groups. According to the report, in 2022, 85% of respondents agreed that DEI is important compared to 68% in 2024. #hresxecutives #DEIB I was interviewed by BioSpace and shared my thoughts on the current state of DEI. Check out the article. https://lnkd.in/dM278Evx

In this article by Healthcare Business Today, Robert Church and Stephanie Agu discuss the importance of diversity and inclusion in clinical trials. Read the full article here: https://lnkd.in/g4aczfju #diversity #inclusion #clinicaltrials

In this article by Healthcare Business Today, Robert Church and Stephanie Agu discuss the importance of diversity and inclusion in clinical trials. Read the full article here: https://lnkd.in/eYde59Ef #diversity #inclusion #clinicaltrials

On September 17th, Patient Safety Day, and every other day, we need to continue to elevate the need for diversity and representation in our clinical trials. Diversity, inclusion and health equity is integral to patient safety. #DiversityInClinicalTrials #HealthEquity #PatientSafety